Showing 1841-1850 of 2526 results for "".
- Dopavision Provides Clinical Trial Update and Announces All MyopiaX-1 Trial Sites Are Activehttps://modernod.com/news/dopavision-provides-clinical-trial-update-and-announces-all-myopiax-1-trial-sites-are-active/2481699/Dopavision announced an update on its MyopiaX-1 trial (NCT04967287). All clinical trial centers are now open and are actively screening and enrolling study participants, providing trial access to eligible children with myopia across Germany, Spain, the Netherlands, and the United Kingdom.
- Euclid Announces ABB Optical Group as Licensed Manufacturer and Distributor of Euclid Ortho-K Lenseshttps://modernod.com/news/euclid-announces-abb-optical-group-as-licensed-manufacturer-and-distributor-of-euclid-ortho-k-lenses/2481691/Euclid Vision has announced that ABB Optical Group is now a licensed manufacturer and distributor of the company’s Ortho-K lenses. Financial terms of the deal were not disclosed. ABB, which Euclid says is the largest distributor of soft lenses in the United States,
- Alcon Announces Results of the Alcon Eye On Cataract Surveyhttps://modernod.com/news/alcon-announces-results-of-the-alcon-eye-on-cataract-survey/2481672/Alcon announced the results of the Alcon Eye On Cataract Survey, which was conducted between March and April 2023 in Australia, Brazil, China, Germany, India, Italy, Japan, Spain, South Korea and the United States. The survey set out to evaluate vision and cataract insights among the wo
- Reduction of Eyedrop Volume for Topical Ophthalmic Medications with the Nanodropper Bottle Adaptorhttps://modernod.com/news/reduction-of-eyedrop-volume-for-topical-ophthalmic-medications-with-the-nanodropper-bottle-adaptor/2481663/Nanodropper announced positive results from a research study conducted in collaboration with Leonard Seibold, MD, Professor of Ophthalmology at University of Colorado School of Medicine, which quantified eyedrop volume reduction and bottle life extension with the Nanodropper adaptor compared
- Pixium Vision Announces Receipt of € 1.8 Million from the French Government as Research Tax Credithttps://modernod.com/news/pixium-vision-announces-receipt-of-eur-18-million-from-the-french-government-as-research-tax-credit/2481661/Pixium Vision SA announced that it has received a €1.8 million Research Tax Credit from the French government. This cash injection will help extend the company’s cash runway until the end of September 2023, providing more flexibility to pursue its longer-term f
- Aviceda Announces Dosing of First Patient With AVD-104, a Novel Glyco-Mimetic Nanoparticle for the Treatment of GAhttps://modernod.com/news/aviceda-announces-dosing-of-first-patient-with-avd-104-a-novel-glyco-mimetic-nanoparticle-for-the-treatment-of-ga/2481647/Aviceda Therapeutics announced the dosing of its first patient with AVD-104 in its phase 2 SIGLEC trial by Ashkan Abbey, MD, of Texas Retina Associates in Dallas. This lead intravitreal asset is a novel glycan-coated nanoparticle, supported by a uniquely strong preclinical in
- Bausch + Lomb Announces Leadership Changeshttps://modernod.com/news/bausch-lomb-announces-leadership-changes/2481644/Bausch + Lomb announced a reshaping of its executive leadership team, including the elevation of all business unit heads. Luc Bonnefoy, senior vice president (SVP), Surgical; John Ferris, SVP, Consumer; and Yang Yang, SVP, Vision Care; will join the executive management team of the comp
- Thea Pharma Launches Preservative Freedom Coalition to Advocate for Preservative-Free Eye Carehttps://modernod.com/news/thea-pharma-launches-preservative-freedom-coalition-to-advocate-for-preservative-free-eye-care/2481639/Thea Pharma announced the launch of the "Preservative Freedom Coalition," which aims to raise awareness of unmet needs in ocular surface disease and opportunities to pursue preservative-free topical ophthalmic medications. In addition to Thea, founding members of the brand-agn
- Dr. Louis R. Pasquale Winner of the Glaucoma Foundation's 2023 Robert Ritch Awardhttps://modernod.com/news/dr-louis-r-pasquale-winner-of-the-glaucoma-foundations-2023-robert-ritch-award/2481629/Louis R. Pasquale, MD, FARVO, has been named the 2023 recipient of The Glaucoma Foundation’s (TGF) Robert Ritch Award for Innovation and Excellence in Glaucoma. Created in 2008, the award recognizes the contributions of individuals who have played a significant and unique role in promoting
- Research: Protein Deletion Could Treat Age and Diabetes-Induced Eye Diseaseshttps://modernod.com/news/research-protein-deletion-could-treat-age-and-diabetes-induced-eye-diseases/2481627/Researchers at the Wayne State University School of Medicine in Detroit say they have provided evidence that depletion of a certain protein in the body can treat age and diabetes-induced retinal diseases, according to a university news release. The protein, called vascular cell ad